These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30268398)

  • 1. Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience.
    Skochko SM; Jain S; Sun X; Sivilay N; Kanegaye JT; Pancheri J; Shimizu C; Sheets R; Tremoulet AH; Burns JC
    J Pediatr; 2018 Dec; 203():408-415.e3. PubMed ID: 30268398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country.
    Mat Bah MN; Alias EY; Razak H; Sapian MH; Foo FH; Abdullah N
    Eur J Pediatr; 2021 Aug; 180(8):2599-2606. PubMed ID: 34086103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence and severity of Kawasaki disease among Filipino-Americans in San Diego county.
    Tremoulet AH; Devera G; Best BM; Jimenez-Fernandez S; Sun X; Jain S; Burns JC
    Pediatr Infect Dis J; 2011 Oct; 30(10):909-11. PubMed ID: 21552184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease.
    Cameron SA; Carr M; Pahl E; DeMarais N; Shulman ST; Rowley AH
    Arch Dis Child; 2019 May; 104(5):451-455. PubMed ID: 30413485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
    Okubo Y; Nochioka K; Sakakibara H; Testa M; Sundel RP
    Clin Rheumatol; 2017 Feb; 36(2):413-419. PubMed ID: 27987089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki disease in New Zealand.
    Heaton P; Wilson N; Nicholson R; Doran J; Parsons A; Aiken G
    J Paediatr Child Health; 2006 Apr; 42(4):184-90. PubMed ID: 16630319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki syndrome and factors associated with coronary artery abnormalities in California.
    Callinan LS; Tabnak F; Holman RC; Maddox RA; Kim JJ; Schonberger LB; Vugia DJ; Belay ED
    Pediatr Infect Dis J; 2012 Sep; 31(9):894-8. PubMed ID: 22565293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.
    Son MBF; Gauvreau K; Tremoulet AH; Lo M; Baker AL; de Ferranti S; Dedeoglu F; Sundel RP; Friedman KG; Burns JC; Newburger JW
    J Am Heart Assoc; 2019 Jun; 8(11):e011319. PubMed ID: 31130036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?
    Porcalla AR; Sable CA; Patel KM; Martin GR; Singh N
    Pediatr Cardiol; 2005; 26(6):775-81. PubMed ID: 16421770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kawasaki disease in Iceland 1996-2005, epidemiology and complications].
    Olafsdottir HS; Oskarsson G; Haraldsson Á
    Laeknabladid; 2012 Feb; 98(2):91-5. PubMed ID: 22314510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
    Burns JC; Roberts SC; Tremoulet AH; He F; Printz BF; Ashouri N; Jain SS; Michalik DE; Sharma K; Truong DT; Wood JB; Kim KK; Jain S;
    Lancet Child Adolesc Health; 2021 Dec; 5(12):852-861. PubMed ID: 34715057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children.
    Garrido-García LM; Morán-Villaseñor E; Yamazaki-Nakashimada MA; Cravioto P; Galván F
    Cardiol Young; 2018 Mar; 28(3):386-390. PubMed ID: 28847341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the Trends of Kawasaki Disease in Hawai'i from 1996 to 2018.
    Dawson TJ; Vuong CT; Ma SCY; Russell CR; Melish ME; Bratincsak A
    Hawaii J Health Soc Welf; 2020 May; 79(5 Suppl 1):104-111. PubMed ID: 32490396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.
    Stasiak A; Smolewska E
    Rheumatol Int; 2019 Jun; 39(6):1069-1076. PubMed ID: 30903369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group.
    Fernandez-Cooke E; Barrios Tascón A; Sánchez-Manubens J; Antón J; Grasa Lozano CD; Aracil Santos J; Villalobos Pinto E; Clemente Garulo D; Mercader Rodríguez B; Bustillo Alonso M; Nuñez Cuadros E; Navarro Gómez ML; Domínguez-Rodríguez S; Calvo C;
    PLoS One; 2019; 14(5):e0215665. PubMed ID: 31107862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.